In validation cohorts, the discovery of a hub shared gene, S100A6, in both PC and T2DM was particularly noteworthy, which may serve as a predictive biomarker for detecting covert PC in T2DM patients. The gene discussed is S100A6; the disease is type 2 diabetes mellitus.